Related Experiment Video
Updated: Jan 13, 2026

08:06
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Published on: January 15, 2010
32.3K
Dopaminergic Degeneration Differentially Modulates Primary Motor Cortex Activity and Motor Behavior in
Suelen L Boschen1,2, Julian Seethaler1, Shaohua Wang1,3
1Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55901, USA.
Brain Sciences
|October 29, 2025
Summary
Parkinson's disease alters primary motor cortex (M1) activity. Levodopa treatment improved motor function and modulated M1 calcium influx in a lesion-dependent manner, suggesting dynamic cortical changes in Parkinson's disease.
Area of Science:
- Neuroscience
- Motor Control
- Neurodegenerative Diseases
Background:
- Parkinson's disease (PD) impairs dopaminergic transmission, affecting motor cortex (M1) activity and causing motor deficits.
- The precise M1 response to dopaminergic degeneration and levodopa treatment is not fully understood.
Purpose of the Study:
- To investigate M1 neuronal activity and motor behavior in hemiparkinsonian rats.
- To characterize changes during naïve, lesioned, and levodopa-treated states using in vivo calcium imaging.
Main Methods:
- Unilateral 6-hydroxydopamine (6-OHDA) lesioning in Sprague Dawley rats.
- In vivo calcium imaging of M1 using GCaMP6f and GRIN lenses.
- Longitudinal assessment of motor behavior (single pellet reaching test) and M1 calcium activity (event frequency and influx).
Main Results:
- Levodopa treatment significantly improved fine motor skills, reducing grasp errors and increasing reaching duration.
- M1 calcium activity modulated with lesion severity: reduced frequency and increased influx in low-lesion rats post-lesion; increased influx in high-lesion rats post-levodopa.
- Calcium influx, not frequency, negatively correlated with lesion severity during levodopa treatment.
Conclusions:
- M1 neuronal activity is differentially modulated by dopaminergic degeneration and levodopa treatment, depending on lesion severity.
- These findings highlight dynamic cortical responses in Parkinson's disease.
- In vivo calcium imaging is a valuable tool for monitoring circuit-level changes in PD and its treatment.
Related Concept Videos
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment
970
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
970
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K

